FDA Inspection 1163560 — Saint Luke's Hospital of Kansas City

Saint Luke's Hospital of Kansas City — FEI 1970696

The FDA completed an inspection of Saint Luke's Hospital of Kansas City on February 28, 2022 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)